X Liu1, W Ma, A Surprenant, L-H Jiang. 1. Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Abstract
BACKGROUND AND PURPOSE: P2X(7), receptors are potently inhibited by extracellular acidification. The underlying molecular basis remains unknown. This study aimed to examine the role of extracellular histidine, lysine, aspartic acid and glutamic acid residues in the functional inhibition of rat P2X(7) receptors by acidic pH. EXPERIMENTAL APPROACH: We introduced point mutations into rat P2X(7) receptor by site-directed mutagenesis, expressed wild type (WT) and mutant receptors in human embryonic kidney (HEK293) cells and, using patch clamp recording, characterized the effects of acidic pH on BzATP [2'-3'O-(4-benzoylbenzoyl) adenosine 5'-triphosphate]-evoked ionic currents. KEY RESULTS: Reducing extracellular pH, that is, increasing extracellular proton concentrations, inhibited BzATP-evoked currents in cells expressing WT P2X(7) receptors, with IC(50) value (half-maximal antagonist or inhibitor concentration) for protons of 0.2 mumol.L(-1). The major effect of acidification was suppression of the maximal current response without altering the agonist sensitivity. five residues in the receptor extracellular domain (His(85), Lys(110), Lys(137), Asp(197) and His(219)) were mutated to alanine and current inhibition by protons assessed. Compared with WT, the H85A, H219A, K137A mutants were two- to threefold more sensitive, whereas the K110A and D197A mutants were 2.5- and 9-fold less sensitive. Double-alanine substitution of Lys(110) and Asp(197) resulted in 23-fold decreased sensitivity to inhibition by protons. Furthermore, charge neutralization (K110M, K110F, D197N and D197F), but not charge conserving mutation (K110R and D197E), attenuated the inhibition of currents by protons. CONCLUSIONS AND IMPLICATIONS: Functional inhibition of rat P2X(7) receptors by acidic pH was variably affected by the extra-cellular His(85), Lys(110), Lys(137), Asp(197) and His(219) residues, with the Asp(197) residue being most critical for this inhibition.
BACKGROUND AND PURPOSE: P2X(7), receptors are potently inhibited by extracellular acidification. The underlying molecular basis remains unknown. This study aimed to examine the role of extracellular histidine, lysine, aspartic acid and glutamic acid residues in the functional inhibition of rat P2X(7) receptors by acidic pH. EXPERIMENTAL APPROACH: We introduced point mutations into rat P2X(7) receptor by site-directed mutagenesis, expressed wild type (WT) and mutant receptors in humanembryonic kidney (HEK293) cells and, using patch clamp recording, characterized the effects of acidic pH on BzATP [2'-3'O-(4-benzoylbenzoyl) adenosine 5'-triphosphate]-evoked ionic currents. KEY RESULTS: Reducing extracellular pH, that is, increasing extracellular proton concentrations, inhibited BzATP-evoked currents in cells expressing WT P2X(7) receptors, with IC(50) value (half-maximal antagonist or inhibitor concentration) for protons of 0.2 mumol.L(-1). The major effect of acidification was suppression of the maximal current response without altering the agonist sensitivity. five residues in the receptor extracellular domain (His(85), Lys(110), Lys(137), Asp(197) and His(219)) were mutated to alanine and current inhibition by protons assessed. Compared with WT, the H85A, H219A, K137A mutants were two- to threefold more sensitive, whereas the K110A and D197A mutants were 2.5- and 9-fold less sensitive. Double-alanine substitution of Lys(110) and Asp(197) resulted in 23-fold decreased sensitivity to inhibition by protons. Furthermore, charge neutralization (K110M, K110F, D197N and D197F), but not charge conserving mutation (K110R and D197E), attenuated the inhibition of currents by protons. CONCLUSIONS AND IMPLICATIONS: Functional inhibition of rat P2X(7) receptors by acidic pH was variably affected by the extra-cellular His(85), Lys(110), Lys(137), Asp(197) and His(219) residues, with the Asp(197) residue being most critical for this inhibition.
Authors: Iain P Chessell; Jonathan P Hatcher; Chas Bountra; Anton D Michel; Jane P Hughes; Paula Green; Julie Egerton; Melanie Murfin; Jill Richardson; Wendy L Peck; Caroline B A Grahames; Maria Anna Casula; Yiangos Yiangou; Rolfe Birch; Praveen Anand; Gary N Buell Journal: Pain Date: 2005-04 Impact factor: 6.961
Authors: Prisca Honore; Diana Donnelly-Roberts; Marian T Namovic; Gin Hsieh; Chang Z Zhu; Joe P Mikusa; Gricelda Hernandez; Chengmin Zhong; Donna M Gauvin; Prasant Chandran; Richard Harris; Arturo Perez Medrano; William Carroll; Kennan Marsh; James P Sullivan; Connie R Faltynek; Michael F Jarvis Journal: J Pharmacol Exp Ther Date: 2006-09-18 Impact factor: 4.030
Authors: Davide Ferrari; Cinzia Pizzirani; Elena Adinolfi; Roberto M Lemoli; Antonio Curti; Marco Idzko; Elisabeth Panther; Francesco Di Virgilio Journal: J Immunol Date: 2006-04-01 Impact factor: 5.422
Authors: Giorgio Fois; Karl J Föhr; Carolin Kling; Michael Fauler; Oliver H Wittekindt; Paul Dietl; Manfred Frick Journal: J Physiol Date: 2018-09-17 Impact factor: 5.182
Authors: Helen J Bradley; Jocelyn M Baldwin; G Ranjan Goli; Brian Johnson; Jie Zou; Asipu Sivaprasadarao; Stephen A Baldwin; Lin-Hua Jiang Journal: J Biol Chem Date: 2011-01-04 Impact factor: 5.157
Authors: Kristiina Rajamäki; Tommy Nordström; Katariina Nurmi; Karl E O Åkerman; Petri T Kovanen; Katariina Öörni; Kari K Eklund Journal: J Biol Chem Date: 2013-03-25 Impact factor: 5.157
Authors: Wei Yang; Jie Zou; Rong Xia; Meriel L Vaal; Victoria A Seymour; Jianhong Luo; David J Beech; Lin-Hua Jiang Journal: J Biol Chem Date: 2010-07-26 Impact factor: 5.157